Penumbra Launches Lightning Flash 2.0 – Latest CAVT Technology Designed to Rapidly Remove Blood Clots
Penumbra, Inc. (NYSE: PEN), the world’s largest thrombectomy company, announced the U.S. Food and Drug Administration (FDA) clearance and launch…
Where health news comes full circle!
Penumbra, Inc. (NYSE: PEN), the world’s largest thrombectomy company, announced the U.S. Food and Drug Administration (FDA) clearance and launch…
OrthoIndy has announced a monumental step forward in surgical innovation by introducing augmented reality (AR) into surgical procedures. Distinguished spine…
In an era of rising health costs, increased time to access providers, and growing frustration, it can be difficult for…
In conventional practice, a blood culture report wouldn’t be available until 18 to 72 hours later, rendering it non-feasible to…
Koning Health, a pioneering medical imaging company, is thrilled to announce that it has received regulatory clearance from the Federal…
ImpediMed, a pioneer in the field of medical technology, announced a significant advancement in the fight against breast cancer-related lymphedema,…
Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced…
By combining years of clinical experience with cutting-edge research and development, IlluminOss Medical announces it has received FDA 510(k) clearance for…
Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today…
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Takeda received European Commission (EC) approval for HYQVIA® [Immune Globulin Infusion 10% (Human)]…